| Date Filed | Type | Description |
| 10/06/2023 |
4
| Trevejo Jose M. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 1,604 shares
@ $18, valued at
$28.9k
|
|
| 10/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/25/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 8,000 shares
@ $17.23, valued at
$137.8k
|
|
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results |
| 08/02/2023 |
8-K
| Quarterly results |
| 08/02/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 07/31/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 07/31/2023 |
8-K
| Quarterly results |
| 07/25/2023 |
8-K
| Quarterly results |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 9,000 shares
@ $18.58, valued at
$167.2k
|
|
| 06/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 3,100 shares
@ $20.01, valued at
$62k
|
|
| 06/12/2023 |
4
| Mottiwala Aziz (Chief Commercial Officer) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 100 shares
@ $20, valued at
$2k
|
|
| 06/08/2023 |
4
| Mottiwala Aziz (Chief Commercial Officer) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 2,143 shares
@ $18.61, valued at
$39.9k
Sold 2,500 shares
@ $19.34, valued at
$48.4k
|
|
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/19/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 8,000 shares
@ $15.9, valued at
$127.2k
|
|
| 05/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
| 05/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/15/2023 |
4
| LINK WILLIAM J PHD (Director) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Disposed of 215,576 shares
@ $0
Acquired 41,219 shares
@ $0 |
|
| 05/12/2023 |
4
| Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 9,000 shares
@ $16.8, valued at
$151.2k
|
|
|